Related Experiment Video
Updated: Apr 23, 2026

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.4K
Androstenedione is the preferred androgen source in hormone refractory prostate cancer--letter
Nima Sharifi1, Richard J Auchus2
1Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio. Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio. Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio. sharifn@ccf.org.
Abstract
No abstract available in PubMed .

